The board of directors of Aarti Drugs on Thursday approved the issuance of fully paid-up bonus share in the ratio of 3:1 (three bonus shares of ₹10 each for one fully paid- up equity share). The company will intimate the 'record date' for determining eligible shareholders entitled to receive bonus shares in due course. The board has also approved the increase in authorised share capital of the company from ₹25 crore to ₹120 crore by creation of additional 9.5 lakh shares. Shares of Aarti Drugs closed 18 per cent higher at ₹2,838.90 on the BSE.
Thank you for being a loyal user of Portfolio.
Portfolio will be a paid section hereon.
Please Subscribe to get access to one of our early bird packs.
Or click on Free Trial to get 14 days free trial.
What You'll Get
-
All Access Plan
Get Full Digital Access To The Hindu BusinessLine, The Hindu, Frontline, Sportstar, Crossword+, Epaper replica of The Hindu and The Hindu BusinessLine in ONE SINGLE DISCOUNTED PRICE!
-
Exclusive Portfolio
Get diverse set of perspectives from our trusted experts on Portfolio, Banking, Economy, Environment and others.
-
Web + Mobile
Access exclusive content of the Hindu Businessline across desktops, tablet and mobile device.
-
Ad free experience
Experience cleaner site with zero ads and faster load times.
-
Personalised dashboard
Customize your preference and get a personalized recommendation of stories based on your interest.
Published on
August 20, 2020
Please Email the Editor